In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIMAB SA

Division of University of Havana
www.cim.sld.cu/cim_ing.asp

Latest From CIMAB SA

Biocon Upbeat As It Tries To Undercut Roche On Herceptin

India’s Biocon has high expectations for its Herceptin biosimilar, but patient groups are vocal in their criticism of the drug’s price in comparison to Roche’s.

BioPharmaceutical India

Deals Shaping The Medical Industry, January 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Pharmaceuticals, and Medical Devices – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Serono Deals Its Way Into Oncology

It ought to be hard to convince an oncology-focused biotech to license its crown jewel to a firm without experience developing oncology drugs, but Serono SA was able to do just that-twice in the span of eight days-when it in-licensed Phase II and Phase III oncology programs, respectively, from Micromet AG and CancerVax Corp. in December.
BioPharmaceutical Strategy

Recent Dealmaking (12/2003)

Summarizing the month in European dealmaking.
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register